NADAC acquisition cost data for AIRDUO DIGIHALER 113-14 MCG. This is a brand-name medication — generic alternatives may be available at lower prices.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 59310012906 | $401.93 | 2022-01-01 | Rx |
| 59310012906 | $401.93 | 2022-01-01 | Rx |
| 59310012906 | $401.93 | 2022-01-01 | Rx |
| 59310012906 | $401.93 | 2022-01-01 | Rx |
| 59310012906 | $401.93 | 2022-01-01 | Rx |
| 59310012906 | $401.93 | 2022-01-01 | Rx |
| 59310012906 | $401.93 | 2022-01-01 | Rx |
| 59310012906 | $401.93 | 2022-01-01 | Rx |
| 59310012906 | $401.93 | 2022-01-01 | Rx |
| 59310012906 | $401.93 | 2022-01-01 | Rx |
Generic: Fluticasone Propion/Salmeterol | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | N/A | N/A | N/A | N/A |
| 2020 | $19.2K | 39 | 33 | $423.50 |
| 2021 | $268.3K | 533 | 321 | $389.71 |
| 2022 | $552.6K | 1,012 | 551 | $448.40 |
| 2023 | $647.6K | 1,064 | 558 | $472.58 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| New Jersey | $106.0K | 165 | 82 |
| Ohio | $54.8K | 83 | 39 |
| California | $43.0K | 74 | 36 |
| Michigan | $37.1K | 54 | 27 |
| Florida | $33.4K | 49 | 30 |
| Texas | $32.8K | 46 | 33 |
| Minnesota | $30.9K | 38 | 13 |
| Illinois | $26.8K | 53 | 19 |
| New York | $25.9K | 49 | 30 |
| Wisconsin | $19.6K | 30 | 15 |
| Pennsylvania | $18.3K | 36 | 22 |
| Arizona | $16.9K | 21 | 14 |
| Indiana | $13.2K | 26 | 13 |
| Connecticut | $13.1K | 18 | N/A |
| North Carolina | $12.7K | 26 | 17 |
| Kentucky | $12.3K | 25 | 11 |
| Nevada | $11.8K | 16 | N/A |
| Maryland | $11.5K | 17 | N/A |
| Massachusetts | $10.9K | 22 | N/A |
| Colorado | $10.5K | 22 | 16 |
| Virginia | $10.2K | 17 | N/A |
| Tennessee | $9.0K | 19 | N/A |
| Missouri | $8.8K | 14 | N/A |
| Utah | $8.4K | 15 | 11 |
| Louisiana | $8.0K | 15 | N/A |
| Washington | $7.6K | 15 | N/A |
| Kansas | $6.7K | 14 | N/A |
| Georgia | $5.1K | 11 | 11 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.